Skip to search formSkip to main contentSkip to account menu

20 ML Bupivacaine liposome 13.3 MG/ML Injection [Exparel]

Known as: 20 ML Exparel 13.3 MG/ML Injection, BUPIVACAINE 13.3 mg in 1 mL INFILTRATION INJECTION, SUSPENSION, LIPOSOMAL [EXPAREL], EXPAREL 1.3 % in 20 ML Injection 
National Institutes of Health

Related topics

Related topics

4 relations
BupivacaineExparelInjection

Broader (1)

Bupivacaine liposome Injection [Exparel]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Lumbar 3-Lumbar 5 Robotic-Assisted Endoscopic Transforaminal Lumbar Interbody Fusion: 2-Dimensional Operative Video.
Minimally invasive spine surgery has the potential to reduce soft tissue destruction, blood loss, postoperative pain, and overall… 
Highly Cited
2018
Highly Cited
2018
Interscalene Block with and without Intraoperative Local Infiltration with Liposomal Bupivacaine in Shoulder Arthroplasty: A Randomized Controlled Trial
Background: Interscalene brachial plexus blockade (ISBPB) is an effective anesthetic technique for shoulder arthroplasty; however… 
Review
2018
Review
2018
Intercostal Nerve Blockade with Exparel® Results in Lower Opioid Usage during the First 24 Hours after Video-Assisted Thorascopic Surgery
Liposomal bupivacaine (LipoB) provides prolonged local anesthetic effects and has seen usage in several fields of surgery. We… 
2017
2017
An evaluation of the analgesic effect of AnestaGel™ on mechanical allodynia in a rat model of postoperative incisional pain
Purpose Sustained release hydrogel with bupivacaine (AnestaGel™) is a novel formulation of extended release bupivacaine in a… 
2016
2016
Does local wound infiltration with liposomal bupivacaine (Exparel®) reduce narcotic requirements or length-of-stay after bariatric operations?
2016
2016
Could the Use of an Enhanced Recovery Protocol in Laparoscopic Donor Nephrectomy be an Incentive for Live Kidney Donation?
Introduction and Background: Gastrointestinal (GI) recovery after major abdominal surgery can be delayed from an ongoing need for… 
2015
2015
Exparel®: A New Local Anesthetic with Special Safety Concerns.
Highly Cited
2013
Highly Cited
2013
Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics…
Background Postoperative opioid use following ileostomy reversal procedures contributes to postoperative ileus. We assessed the… 
Highly Cited
2013
Highly Cited
2013
Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty.
Pain following orthopedic surgery is common and often suboptimally managed, with many patients reporting acute moderate to severe… 
Highly Cited
2011
Highly Cited
2011
Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison
EXPAREL (bupivacaine extended-release liposome injection), DepoFoam bupivacaine, is in development for prolonged postsurgical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)